concizumab-mtci bulk supplier for pharma manufacturers

Concizumab-Mtci Suppliers & Bulk Manufacturers

Available Forms: Prefilled autoinjector

Available Strengths: 60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL

Reference Brands: Alhemo (USA/EU)

Concizumab is a monoclonal antibody used for the routine prophylaxis of bleeding episodes in patients with hemophilia A or B, with or without inhibitors. It works by inhibiting tissue factor pathway inhibitor (TFPI), helping restore blood clotting and reduce the frequency of bleeds. The drug is administered as a subcutaneous injection using a prefilled pen. It is indicated for adolescents and adults aged 12 years and older.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Concizumab-Mtci — third party manufacturing & bulk supply

Concizumab-Mtci is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Concizumab-Mtci is supplied as Prefilled autoinjector — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Concizumab-Mtci listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Concizumab-Mtci →

Back to Listing

Frequently Asked Questions

concizumab-mtci is listed as Prefilled autoinjector in 60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

concizumab-mtci is referenced against Alhemo (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.